Filing Details
- Accession Number:
- 0001209191-22-046894
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-19 17:28:49
- Reporting Period:
- 2022-07-01
- Accepted Time:
- 2022-08-19 17:28:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1695580 | Kenneth Krogulski | 2525 West End Avenue Suite 950 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-07-01 | 130 | $2.11 | 190,464 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-05 | 144 | $2.18 | 190,608 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-06 | 144 | $2.11 | 190,752 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-07 | 144 | $2.18 | 190,896 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-08 | 144 | $2.19 | 191,040 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-12 | 144 | $2.25 | 191,184 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-14 | 144 | $2.28 | 191,328 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-15 | 144 | $2.23 | 191,472 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-18 | 124 | $2.41 | 191,596 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-19 | 124 | $2.47 | 191,720 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-20 | 124 | $2.52 | 191,844 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-21 | 124 | $2.54 | 191,968 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-22 | 124 | $2.53 | 192,092 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-25 | 124 | $2.48 | 192,216 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-26 | 124 | $2.47 | 192,340 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-27 | 90 | $2.36 | 192,430 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-28 | 124 | $2.28 | 192,554 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-29 | 124 | $2.28 | 192,678 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-01 | 124 | $2.34 | 192,802 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-03 | 50 | $2.45 | 192,852 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-04 | 124 | $2.17 | 192,976 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-05 | 124 | $2.12 | 193,100 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-08 | 138 | $2.19 | 193,238 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-09 | 138 | $2.19 | 193,376 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-10 | 138 | $2.19 | 193,514 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-11 | 138 | $2.46 | 193,652 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-12 | 138 | $2.52 | 193,790 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-15 | 110 | $2.45 | 193,900 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.